Literature DB >> 18628606

Epidemic of equine influenza among vaccinated racehorses in Japan in 2007.

Takashi Yamanaka1, Hidekazu Niwa, Koji Tsujimura, Takashi Kondo, Tomio Matsumura.   

Abstract

On August 2007, we encountered equine influenza epidemic by Florida sub-lineage strain (H3N8) in Japan Racing Association's facilities where 4142 racehorses in total were stabled. The number of new febrile cases sharply increased, but the occurrence was rapidly calmed down within 2 weeks. The morbidity rate in these facilities was 12.8% and the subclinical infection rate of healthy racehorses examined by rapid antigen detection tests was 19.4% at the early stage of epidemic. The serological studies along with the low morbidity rate and the existence of numbers of asymptomatically infected racehorses, suggested that the cross-reactivity of the antibodies provided by vaccination against the epidemic strain contributed to reducing the morbidity rate and duration of epidemic.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18628606     DOI: 10.1292/jvms.70.623

Source DB:  PubMed          Journal:  J Vet Med Sci        ISSN: 0916-7250            Impact factor:   1.267


  31 in total

1.  Equine Influenza Virus in Asia: Phylogeographic Pattern and Molecular Features Reveal Circulation of an Autochthonous Lineage.

Authors:  Samuel Miño; Laura Mojsiejczuk; Wei Guo; Haili Zhang; Ting Qi; Cheng Du; Xiang Zhang; Jingfei Wang; Rodolfo Campos; Xiaojun Wang
Journal:  J Virol       Date:  2019-06-14       Impact factor: 5.103

2.  Genetic Analysis of the Neuraminidase (NA) Gene of Equine Influenza Virus (H3N8) from Epizootic of 2008-2009 in India.

Authors:  B C Bera; N Virmani; K Shanmugasundaram; R K Vaid; B K Singh; B R Gulati; T Anand; S Barua; P Malik; R K Singh
Journal:  Indian J Virol       Date:  2013-05-24

3.  Epidemiological and virological investigations of equine influenza outbreaks in Ireland (2010-2012).

Authors:  Sarah Gildea; David A Fitzpatrick; Ann Cullinane
Journal:  Influenza Other Respir Viruses       Date:  2013-12       Impact factor: 4.380

4.  Epidemiological and virological findings during multiple outbreaks of equine influenza in South America in 2012.

Authors:  Cecilia Olguin Perglione; Sarah Gildea; Agustina Rimondi; Samuel Miño; Aldana Vissani; Mariano Carossino; Ann Cullinane; Maria Barrandeguy
Journal:  Influenza Other Respir Viruses       Date:  2016-01       Impact factor: 4.380

Review 5.  Equine influenza - surveillance and control.

Authors:  Ann Cullinane; Debra Elton; Jenny Mumford
Journal:  Influenza Other Respir Viruses       Date:  2010-11       Impact factor: 4.380

6.  Using Bayes' rule to define the value of evidence from syndromic surveillance.

Authors:  Mats Gunnar Andersson; Céline Faverjon; Flavie Vial; Loïc Legrand; Agnès Leblond
Journal:  PLoS One       Date:  2014-11-03       Impact factor: 3.240

7.  Comparison of two modern vaccines and previous influenza infection against challenge with an equine influenza virus from the Australian 2007 outbreak.

Authors:  Neil A Bryant; Romain Paillot; Adam S Rash; Elizabeth Medcalf; Fernando Montesso; Julie Ross; James Watson; Martyn Jeggo; Nicola S Lewis; J Richard Newton; Debra M Elton
Journal:  Vet Res       Date:  2009-10-29       Impact factor: 3.683

Review 8.  A Systematic Review of Recent Advances in Equine Influenza Vaccination.

Authors:  Romain Paillot
Journal:  Vaccines (Basel)       Date:  2014-11-14

9.  Time-related Pathological Changes in Horses Experimentally Inoculated with Equine Influenza A Virus.

Authors:  Masanori Muranaka; Takashi Yamanaka; Yoshinari Katayama; Hidekazu Niwa; Kazuomi Oku; Tomio Matsumura; Toshifumi Oyamada
Journal:  J Equine Sci       Date:  2012-07-06

10.  Evaluation of twenty-two rapid antigen detection tests in the diagnosis of Equine Influenza caused by viruses of H3N8 subtype.

Authors:  Takashi Yamanaka; Manabu Nemoto; Hiroshi Bannai; Koji Tsujimura; Takashi Kondo; Tomio Matsumura; Sarah Gildea; Ann Cullinane
Journal:  Influenza Other Respir Viruses       Date:  2016-02-01       Impact factor: 4.380

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.